179 related articles for article (PubMed ID: 22633748)
1. How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? A short report.
Yumuk PF; Mohammed N; Maat AP; Fink C; Marchal B; O'Brien ME
Eur J Cancer; 2012 Sep; 48(14):2163-5. PubMed ID: 22633748
[TBL] [Abstract][Full Text] [Related]
2. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.
Choi SH; Kim YT; Kim SK; Kang KW; Goo JM; Kang CH; Kim JH
Ann Thorac Surg; 2011 Nov; 92(5):1826-32; discussion 1832. PubMed ID: 22051278
[TBL] [Abstract][Full Text] [Related]
4. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.
Coon D; Gokhale AS; Burton SA; Heron DE; Ozhasoglu C; Christie N
Clin Lung Cancer; 2008 Jul; 9(4):217-21. PubMed ID: 18650169
[TBL] [Abstract][Full Text] [Related]
5. Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation.
Gross BH; Brown RK; Kalemkerian GP
Lung Cancer; 2011 Jul; 73(1):59-62. PubMed ID: 21094559
[TBL] [Abstract][Full Text] [Related]
6. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
7. A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients.
Cho S; Lee EB
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1447-51. PubMed ID: 20005529
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma.
Eradat J; Abtin F; Gutierrez A; Suh R
Cancer J; 2011; 17(1):38-48. PubMed ID: 21263266
[TBL] [Abstract][Full Text] [Related]
10. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
[TBL] [Abstract][Full Text] [Related]
11. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
12. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
[TBL] [Abstract][Full Text] [Related]
14. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
16. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
17. Imaging lung cancer.
Patz EF
Semin Oncol; 1999 Oct; 26(5 Suppl 15):21-6. PubMed ID: 10566607
[TBL] [Abstract][Full Text] [Related]
18. [Guideline on 'non-small cell lung carcinoma; staging and treatment'].
van Meerbeeck JP; Koning CC; Tjan-Heijnen VC; Boekema AG; Kaandorp CJ; Burgers JS
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):72-7. PubMed ID: 15688837
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
20. The role of integrated positron emission tomography-computerized tomography in evaluating and staging patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Semin Thorac Cardiovasc Surg; 2007; 19(3):192-200. PubMed ID: 17983944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
